Literature DB >> 12200807

Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients.

Vincenzo Bellizzi1, Roberto Minutolo, Vincenzo Terracciano, Carmela Iodice, Paolo Giannattasio, Luca De Nicola, Giuseppe Conte, Biagio R Di Iorio.   

Abstract

BACKGROUND: Maintenance hemodialysis (HD) patients were studied to assess the effect on hemoglobin (Hb) concentration induced by the cyclic variation in hydration status.
METHODS: Forty-nine HD patients were examined in three consecutive HD sessions in a 1-week treatment period. In a subgroup of 23 patients, Hb levels also were investigated during the long interdialytic interval.
RESULTS: Hb levels at the end of the long interdialytic interval were significantly lower by 0.5 to 0.6 g/dL (5 to 6 g/L) than those at the end of short intervals. Among all pre-HD and post-HD Hb values, levels measured at the end of short intervals were closest to the mean Hb value of the week, derived from calculation of the area under the curve (12.0 +/- 0.2 g/dL [120 +/- 2 g/L]). Intradialytic Hb increments were different in the three sessions (+1.6 +/- 0.1 g/dL [+16 +/- 1 g/L] after the long interval, +1.1 +/- 0.1 g/dL [+11 +/- 1 g/L] and +1.1 +/- 0.1 g/dL [+11 +/- 1 g/L] after short intervals [P < 0.001] and proportionate to weight loss [-3.4 +/- 0.1, -2.7 +/- 0.1, and -2.6 +/- 0.1 kg, respectively; P < 0.001]). Hb level increment and weight loss correlated directly (r = 0.527; P < 0.0001); each 1 L of ultrafiltration (UF) led to an increase in Hb level of approximately 0.4 g/dL (4 g/L). Plasma refilling accounted for an approximately 45% decrement in the intradialytic increase in Hb level 2 hours post-HD.
CONCLUSION: This study suggests that: (1) the end of the short interdialytic period is the most appropriate timing for anemia assessment, and (2) the remarkable hemodiluting effect of post-HD plasma refilling protects against excessive increments in Hb levels induced by UF. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200807     DOI: 10.1053/ajkd.2002.34913

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients.

Authors:  Alexander Kainz; Bernd Mayer; Reinhard Kramar; Rainer Oberbauer
Journal:  Nephrol Dial Transplant       Date:  2010-05-26       Impact factor: 5.992

2.  Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan.

Authors:  Takashi Hara; Miho Kimachi; Tatsuyoshi Ikenoue; Tadao Akizawa; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  Am J Nephrol       Date:  2019-09-05       Impact factor: 3.754

3.  Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study.

Authors:  Esteban Siga; Miguel Fernandez; Mario Galarza; Vito Mesina; Hugo De Palma; Raul Coste
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

4.  Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients.

Authors:  Roozbeh Jamshid; Serati Ali Reza; Ghaderi Abbas; Afshariani Raha
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

5.  Morbidity and mortality in children with anemia at initiation of dialysis.

Authors:  Bradley A Warady; Martin Ho
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

6.  Dosing of erythropoiesis-stimulating agents can be reduced by a new administration regimen.

Authors:  Bergur V Stefánsson; Börje Haraldsson; Ulf Nilsson
Journal:  Nephron Extra       Date:  2011-08-19

7.  Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost.

Authors:  Mohammad Mahdi Sagheb; Mohammad Amin Fallahzadeh; Alireza Moaref; Mohammad Hossein Fallahzadeh; Banafshe Dormanesh
Journal:  Nephrourol Mon       Date:  2016-06-29

8.  Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study.

Authors:  Nieves Castillo; Patricia García-García; Antonio Rivero; Alejandro Jiménez-Sosa; Manuel Macía; María Adela Getino; María Luisa Méndez; Javier García-Pérez; Juan F Navarro-González
Journal:  BMC Nephrol       Date:  2012-07-16       Impact factor: 2.388

9.  Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.

Authors:  Valentina Forni; Giorgia Bianchi; Adam Ogna; Igor Salvadé; Philippe Vuistiner; Michel Burnier; Luca Gabutti
Journal:  BMC Nephrol       Date:  2013-07-22       Impact factor: 2.388

10.  Erratum: Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events.

Authors:  Takashi Hara; Miho Kimachi; Tadao Akizawa; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  Kidney Int Rep       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.